Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | -0.24% | 83.07 | 0.9% | $974.14m | |
| KITE | Kite Pharma, Inc. | 0.05% | 179.39 | 16.1% | $742.45m | |
| CELG | Celgene Corporation | 0.52% | 144.64 | 1.1% | $500.32m | |
| AMGN | Amgen Inc. | 0.28% | 186.28 | 1.1% | $484.51m | |
| BIIB | Biogen Inc. | -0.10% | 318.14 | 1.2% | $421.93m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 1.44% | 438.96 | 2.7% | $359.45m | |
| ALNY | Alnylam Pharmaceuticals, Inc | 1.99% | 116.06 | 10.7% | $250.60m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.36% | 143.34 | 1.9% | $229.81m | |
| JUNO | Juno Therapeutics, Inc. | -4.85% | 42.95 | 14.6% | $225.26m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -1.05% | 149.67 | 1.9% | $209.15m | |
| INCY | Incyte Corporation | -1.18% | 109.54 | 2.6% | $205.20m | |
| ILMN | Illumina, Inc. | -0.54% | 200.33 | 3.5% | $158.56m | |
| BLUE | Bluebird Bio, Inc. | 1.24% | 130.35 | 19.3% | $143.20m | |
| BMRN | BioMarin Pharmaceutical Inc. | -0.52% | 94.46 | 4.4% | $136.68m | |
| CLVS | Clovis Oncology, Inc. | -3.04% | 76.17 | 18.0% | $132.29m |
Company Profile
Arena Pharmaceuticals, Inc. is a biopharmaceutical company engages in the discovery, development, and commercialization of novel drugs that target G protien-coupled receptors. It offers a range of drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in San Diego, CA.